Sealbond Ltd - 21 Nov 2025 SCHEDULE 13D/A Report for Dogwood Therapeutics, Inc. Common Stock, $0.0001 par value (DWTX)

Filing Manager
Sealbond Ltd
Reporting Manager
CK Life Sciences Int'l., (Holdings) Inc.
Security
Dogwood Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol
DWTX
Shares outstanding
29,716,833 shares
Disclosed Ownership
24,664,971 shares
Ownership
83%
Form type
SCHEDULE 13D/A
Filing time
25 Nov 2025, 17:30:20 UTC
Date of event
21 Nov 2025
Previous filing
17 Mar 2025
SEC
View on sec.gov

Quoteable Key Fact

"Sealbond Ltd disclosed 83% ownership in Dogwood Therapeutics, Inc. Common Stock, $0.0001 par value (DWTX) on 21 Nov 2025."

Quick Takeaways

  • Sealbond Ltd filed SCHEDULE 13D/A for Dogwood Therapeutics, Inc. Common Stock, $0.0001 par value (DWTX).
  • Disclosed ownership: 83%.
  • Date of event: 21 Nov 2025.

What Changed

  • Previous schedule filing date: 17 Mar 2025.
  • Current filing was accepted on 25 Nov 2025, 17:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sealbond Limited 73% 21,822,333 21,822,333 0 /s/ Wong Wun Lam Wong Wun Lam, Director 0002040446
CK Life Sciences Int'l., (Holdings) Inc. 83% 24,664,971 24,664,971 0 /s/ Yu Ying Choi Alan Abel Yu Ying Choi Alan Abel, Director
Conjoint Inc. 9.6% 2,842,638 2,842,638 0 /s/ Wong Wun Lam Wong Wun Lam, Director